Barr Announces Reorganization of Senior Management, Business...(my strategicresponsibilities as CEO and ...),Health

Date:3/28/2008

my strategic responsibilities as CEO and Chairman. I am pleased that we have moved from the transitional period resulting from the integration of Barr and PLIVA, which we began in 2006, to more efficiently operating a global organization focused on generating increased profitability and optimizing the capabilities of the combined company."

"The senior management team at Barr has long been recognized internally and externally as among the most talented in the industry, and their individual and collective contributions are critical to our success in the specialty pharmaceuticals sector. Today, I am pleased to elevate these key executives to additional significant areas of responsibility and I am confident that they possess the right skills and business acumen to deliver on our objectives of enhancing profitability and operational efficiency for our shareholders and our employees."

Mundkur Named Chief Executive Officer of Barr Laboratories, Inc.

In her new position, Christine Mundkur will have responsibility for Barr's global generics business, including strategic planning, research and development, regulatory affairs, operations, quality, and sales and marketing. Under her leadership, Barr Laboratories will continue to provide support to the proprietary business in the areas of formulation, regulatory affairs and product supply. She joined Barr in 1993 as an associate counsel and was named regulatory counsel and director of regulatory affairs in 1997. In 1998, Mundkur was promoted to Vice President, Quality and Regulatory Counsel. In 2001, she was promoted to Senior Vice President of Quality and Regulatory Counsel. Mundkur most recently served as Executive Vice President Global Quality, Safety and Regulatory Affairs, and had responsibility for leading the Company's global quality, safety, regulatory affairs and PK/BE operations. During 2007, Christine lived and worked in the Company's European headquarters in Zagreb, Croatia.

Wilkinson Nam
'/>"/>

SOURCE Barr Pharmaceuticals, Inc. Copyright©2008 PR Newswire. All rights reserved

0 GOOD

Page: 1 2 3 4 5 6 7
Related medicine news :

1. HHS Announces $75 Million in Supplemental Funding to States for Pandemic Flu Preparedness
2. CRC Health Group Announces Acquisition of Bayside Marin Recovery Center, San Rafael
3. UHW Announces: Antelope Valley Hospital Caregivers and Board Vote to Ratify First Union Contract With SEIU UHW-West
4. HEI, Inc. Announces Sale of RFID Division Assets
5. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
6. Mettler-Toledo International Inc. Announces Webcast of Presentation at Thomas Weisel Partners 2007 Healthcare Conference
7. Z Trim Announces Revocation of Gregory Halpern Severence Agreement
8. Brooke Franchise Corporation Announces Selected July Results
9. Manor Care, Inc. Announces Record Date for Special Stockholder Meeting
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
11. Planet Technologies Announces Agreement to Acquire Antigen Laboratories